Article
Dallas - Low-dose Propecia (finasteride, Merck), used to treat hair loss, appears to suppress prostate specific antigen (PSA) levels, which could skew results of prostate cancer tests, researchers say.
Vitiligo, Melasma, PIH, and Albinism: Clinical Update and Emerging Therapies
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
Top 5 Articles of the Week: February 2-7
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
Rezpegaldesleukin Receives Fast Track Designation for Moderate to Severe AD
Topical Corticosteroids: Potency, Vehicles, and Best Practices